Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disease characterized by the presence of excessive amounts of paraprotein or single monoclonal gammaglobulin in the blood. It is usually due to an underlying immunoproliferative disorder or hematologic neoplasms, especially multiple myeloma.
Biomarker and diagnostic research for monoclonal paraproteinemia disease has been reported in the published literature.
No clinical trials have been registered for monoclonal paraproteinemia disease.
218 publications have been identified in PubMed for monoclonal paraproteinemia disease. Research spans Review / Meta-Analysis (40%), Basic Science / Preclinical (20%), and Case Report / Case Series (12%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 87 | 40% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 6:02 PM UTC
Laboratory research
44 |
20% |
Patient case studies | 25 | 12% |
Disease patterns and progression | 23 | 11% |
Clinical study results | 19 | 9% |
Testing and diagnosis research | 16 | 7% |
New treatment approaches | 1 | 0% |
Blumenberg V (2026). [PMID: 41592291](https://pubmed.ncbi.nlm.nih.gov/41592291/). *Blood*. [Case Report / Case Series]
Jingliang Z (2026). [PMID: 41733408](https://pubmed.ncbi.nlm.nih.gov/41733408/). *Eur J Haematol*. [Review / Meta-Analysis]
Xin X (2026). [PMID: 41706224](https://pubmed.ncbi.nlm.nih.gov/41706224/). *Clin Exp Med*. [Review / Meta-Analysis]
Kaeser SA (2026). [PMID: 41814005](https://pubmed.ncbi.nlm.nih.gov/41814005/). *Nat Med*. [Diagnostic / Biomarker]
Longhino S (2026). [PMID: 42030799](https://pubmed.ncbi.nlm.nih.gov/42030799/). *Semin Arthritis Rheum*. [Epidemiology / Natural History]
van Veen R (2026). [PMID: 41819123](https://pubmed.ncbi.nlm.nih.gov/41819123/). *Journal of the peripheral nervous system : JPNS*. [Epidemiology / Natural History]
Gödecke V (2026). [PMID: 42012503](https://pubmed.ncbi.nlm.nih.gov/42012503/). *Inn Med (Heidelb)*. [Review / Meta-Analysis]
Tentolouris A (2026). [PMID: 41123105](https://pubmed.ncbi.nlm.nih.gov/41123105/). *Eur J Clin Invest*. [Epidemiology / Natural History]
Mir TH (2026). [PMID: 41850491](https://pubmed.ncbi.nlm.nih.gov/41850491/). *J Thromb Haemost*. [Review / Meta-Analysis]
Cervantes CE (2026). [PMID: 38865984](https://pubmed.ncbi.nlm.nih.gov/38865984/). *Am J Nephrol*. [Review / Meta-Analysis]